Morning Trend | NUOBIKAN consolidates sideways, no obvious catalysts in the medical equipment sector

NUOBIKAN (2635.HK) maintained a sideways consolidation yesterday, with limited intraday volatility. The MACD golden cross pattern continues horizontally but with weakened momentum. Currently, the medical equipment sector lacks obvious catalysts, and market participants are operating cautiously. NUOBIKAN's stock price has repeatedly tested the 5-day and 10-day moving averages for support, but the upward pressure has not seen a breakthrough, showing a trend of shrinking volume consolidation. From a fundamental analysis perspective, the progress of clinical trials and market promotion of the company's product pipeline are medium to long-term highlights, but there have been no significant breakthroughs or positive news in the short term. The industrial policy front is relatively flat, and market sentiment is heavily wait-and-see. The continuous reduction in trading volume indicates increasing divergence among funds, with major players remaining on the sidelines. In terms of investment advice, short-term attention should be paid to market fluctuations and fund status. If there are new changes in industry policies or significant project progress, it may ignite the enthusiasm of funds for aggressive investment. Otherwise, the sideways pattern will continue, and it is recommended to mainly adopt a wait-and-see approach, with only strategic investors suitable for gradual low-cost buying, while short-term funds should avoid participating in high-volatility operations